Author: Gerhard Schroeck
Publisher: John Wiley & Sons
ISBN: 0471429740
Category : Business & Economics
Languages : en
Pages : 354
Book Description
An analysis of the links between risk management and value creation Risk Management and Value Creation in Financial Institutions explores a variety of methods that can be utilized to create economic value at financial institutions. This invaluable resource shows how banks can use risk management to create value for shareholders, addresses the advantages of risk-adjusted return on capital (RAROC) measures, and develops the foundations for a model to identify comparative advantages that emerge as a result of risk-management decisions. It is the only book needed for banking executives interested in the relationship between risk management and value creation.
Risk Management and Value Creation in Financial Institutions
Author: Gerhard Schroeck
Publisher: John Wiley & Sons
ISBN: 0471429740
Category : Business & Economics
Languages : en
Pages : 354
Book Description
An analysis of the links between risk management and value creation Risk Management and Value Creation in Financial Institutions explores a variety of methods that can be utilized to create economic value at financial institutions. This invaluable resource shows how banks can use risk management to create value for shareholders, addresses the advantages of risk-adjusted return on capital (RAROC) measures, and develops the foundations for a model to identify comparative advantages that emerge as a result of risk-management decisions. It is the only book needed for banking executives interested in the relationship between risk management and value creation.
Publisher: John Wiley & Sons
ISBN: 0471429740
Category : Business & Economics
Languages : en
Pages : 354
Book Description
An analysis of the links between risk management and value creation Risk Management and Value Creation in Financial Institutions explores a variety of methods that can be utilized to create economic value at financial institutions. This invaluable resource shows how banks can use risk management to create value for shareholders, addresses the advantages of risk-adjusted return on capital (RAROC) measures, and develops the foundations for a model to identify comparative advantages that emerge as a result of risk-management decisions. It is the only book needed for banking executives interested in the relationship between risk management and value creation.
Pharmocracy
Author: Kaushik Sunder Rajan
Publisher: Duke University Press Books
ISBN: 9780822363132
Category : Social Science
Languages : en
Pages : 0
Book Description
Continuing his pioneering theoretical explorations into the relationships among biosciences, the market, and political economy, Kaushik Sunder Rajan introduces the concept of pharmocracy to explain the structure and operation of the global hegemony of the multinational pharmaceutical industry. He reveals pharmocracy's logic in two case studies from contemporary India: the controversial introduction of an HPV vaccine in 2010, and the Indian Patent Office's denial of a patent for an anticancer drug in 2006 and ensuing legal battles. In each instance health was appropriated by capital and transformed from an embodied state of well-being into an abstract category made subject to capital's interests. These cases demonstrate the precarious situation in which pharmocracy places democracy, as India's accommodation of global pharmaceutical regulatory frameworks pits the interests of its citizens against those of international capital. Sunder Rajan's insights into this dynamic make clear the high stakes of pharmocracy's intersection with health, politics, and democracy.
Publisher: Duke University Press Books
ISBN: 9780822363132
Category : Social Science
Languages : en
Pages : 0
Book Description
Continuing his pioneering theoretical explorations into the relationships among biosciences, the market, and political economy, Kaushik Sunder Rajan introduces the concept of pharmocracy to explain the structure and operation of the global hegemony of the multinational pharmaceutical industry. He reveals pharmocracy's logic in two case studies from contemporary India: the controversial introduction of an HPV vaccine in 2010, and the Indian Patent Office's denial of a patent for an anticancer drug in 2006 and ensuing legal battles. In each instance health was appropriated by capital and transformed from an embodied state of well-being into an abstract category made subject to capital's interests. These cases demonstrate the precarious situation in which pharmocracy places democracy, as India's accommodation of global pharmaceutical regulatory frameworks pits the interests of its citizens against those of international capital. Sunder Rajan's insights into this dynamic make clear the high stakes of pharmocracy's intersection with health, politics, and democracy.
Research and Development in the Pharmaceutical Industry (A CBO Study)
Author: Congressional Budget Office
Publisher: Lulu.com
ISBN: 1304121445
Category : Science
Languages : en
Pages : 65
Book Description
Perceptions that the pace of new-drug development has slowed and that the pharmaceutical industry is highly profitable have sparked concerns that significant problems loom for future drug development. This Congressional Budget Office (CBO) study-prepared at the request of the Senate Majority Leader-reviews basic facts about the drug industry's recent spending on research and development (R&D) and its output of new drugs. The study also examines issues relating to the costs of R&D, the federal government's role in pharmaceutical research, the performance of the pharmaceutical industry in developing innovative drugs, and the role of expected profits in private firms' decisions about investing in drug R&D. In keeping with CBO's mandate to provide objective, impartial analysis, the study makes no recommendations. David H. Austin prepared this report under the supervision of Joseph Kile and David Moore. Colin Baker provided valuable consultation...
Publisher: Lulu.com
ISBN: 1304121445
Category : Science
Languages : en
Pages : 65
Book Description
Perceptions that the pace of new-drug development has slowed and that the pharmaceutical industry is highly profitable have sparked concerns that significant problems loom for future drug development. This Congressional Budget Office (CBO) study-prepared at the request of the Senate Majority Leader-reviews basic facts about the drug industry's recent spending on research and development (R&D) and its output of new drugs. The study also examines issues relating to the costs of R&D, the federal government's role in pharmaceutical research, the performance of the pharmaceutical industry in developing innovative drugs, and the role of expected profits in private firms' decisions about investing in drug R&D. In keeping with CBO's mandate to provide objective, impartial analysis, the study makes no recommendations. David H. Austin prepared this report under the supervision of Joseph Kile and David Moore. Colin Baker provided valuable consultation...
NEW PERSPECTIVES ON COMMERCE & MANAGEMENT VOLUME-1
Author: Sruthi. S, Dr.Pragya Singh ,Er. Yogendra Kumar
Publisher: Nitya Publications
ISBN: 9391669093
Category : Business & Economics
Languages : en
Pages : 286
Book Description
Publisher: Nitya Publications
ISBN: 9391669093
Category : Business & Economics
Languages : en
Pages : 286
Book Description
The Influence of the Pharmaceutical Industry
Author: Great Britain: Parliament: House of Commons: Health Committee
Publisher: The Stationery Office
ISBN: 9780215024572
Category : Political Science
Languages : en
Pages : 556
Book Description
Incorporating HC 1030-i to iii.
Publisher: The Stationery Office
ISBN: 9780215024572
Category : Political Science
Languages : en
Pages : 556
Book Description
Incorporating HC 1030-i to iii.
Investment Analysis and Portfolio Management
Author: M. Ranganatham
Publisher: Pearson Education India
ISBN: 9788177582291
Category : Business enterprises
Languages : en
Pages : 544
Book Description
The world of investment is fascinating and, at the same time, enigmatic. The investor's behaviour the world over had oscillated between panic and enthusiasm, guided by the psychological forces of fear and greed. Only knowledgeable investors can minimize investment-related risks through systematic planning and efficient and effective management of their investments. Investment Analysis and Portfolio Management helps you gain that knowlegde. It will be useful to academicians and practitioners and offers a scientific approach to investment management, comprehensive coverage of theory, tools, and techniques of investments, a focus on stock market instruments and is richly illustrated to help understand methods of processing investment information.
Publisher: Pearson Education India
ISBN: 9788177582291
Category : Business enterprises
Languages : en
Pages : 544
Book Description
The world of investment is fascinating and, at the same time, enigmatic. The investor's behaviour the world over had oscillated between panic and enthusiasm, guided by the psychological forces of fear and greed. Only knowledgeable investors can minimize investment-related risks through systematic planning and efficient and effective management of their investments. Investment Analysis and Portfolio Management helps you gain that knowlegde. It will be useful to academicians and practitioners and offers a scientific approach to investment management, comprehensive coverage of theory, tools, and techniques of investments, a focus on stock market instruments and is richly illustrated to help understand methods of processing investment information.
Security Analysis and Portfolio Management:
Author: Ranganatham
Publisher: Pearson Education India
ISBN: 9332506701
Category :
Languages : en
Pages : 793
Book Description
The revised and enlarged second edition of Security Analysis and Portfolio Management provides a more comprehensive coverage of concepts. It has been expanded to strengthen the conceptual foundation and incorporates the latest research and up-to-date thinking in all the chapters. This edition contains completely new chapters on portfolio risk analysis, portfolio building process, mutual fund management, portfolio performance evaluations and hedging portfolio risk have been included. The volume also contains an Indian perspective that has been presented through cases and examples to help students from Indian business schools relate to the concepts discussed. Each chapter begins with a feature called ‘The Situation’, in which managers in a fictitious company must make certain key decisions in the derivatives market.
Publisher: Pearson Education India
ISBN: 9332506701
Category :
Languages : en
Pages : 793
Book Description
The revised and enlarged second edition of Security Analysis and Portfolio Management provides a more comprehensive coverage of concepts. It has been expanded to strengthen the conceptual foundation and incorporates the latest research and up-to-date thinking in all the chapters. This edition contains completely new chapters on portfolio risk analysis, portfolio building process, mutual fund management, portfolio performance evaluations and hedging portfolio risk have been included. The volume also contains an Indian perspective that has been presented through cases and examples to help students from Indian business schools relate to the concepts discussed. Each chapter begins with a feature called ‘The Situation’, in which managers in a fictitious company must make certain key decisions in the derivatives market.
Relationship between R&D and Financial Performance in Indian Pharmaceutical Industry
Author: Mithun Nandy
Publisher: Springer Nature
ISBN: 981166921X
Category : Business & Economics
Languages : en
Pages : 224
Book Description
The book provides insight into different research and development (R&D) activities performed by Indian pharmaceutical companies. It describes how R&D activities have evolved in the last three decades on Indian soil. The book discusses how emerging economy like India has become the ‘Pharmacy of the World’ and how reputed and research-centric Indian drug manufacturing companies are aligning their business model by incepting the business idea as ‘Innovate in India and Serve to the World’. Subsequently, through successful implementation of the R&D activities and endeavors, Indian pharmaceutical companies have been witnessing different drug discoveries and innovations which have been performed in an indigenous manner. Contemporary marketing strategies adopted by the research-centric Indian pharmaceutical companies for selling innovative drug products across the globe, attaining global competitiveness, and maintaining a seamless supply chain through export initiatives have also been discussed in this book. Finally, the book figures out the relationship between R&D and financial performance with the help of panel data analysis (PDA), an econometric approach.
Publisher: Springer Nature
ISBN: 981166921X
Category : Business & Economics
Languages : en
Pages : 224
Book Description
The book provides insight into different research and development (R&D) activities performed by Indian pharmaceutical companies. It describes how R&D activities have evolved in the last three decades on Indian soil. The book discusses how emerging economy like India has become the ‘Pharmacy of the World’ and how reputed and research-centric Indian drug manufacturing companies are aligning their business model by incepting the business idea as ‘Innovate in India and Serve to the World’. Subsequently, through successful implementation of the R&D activities and endeavors, Indian pharmaceutical companies have been witnessing different drug discoveries and innovations which have been performed in an indigenous manner. Contemporary marketing strategies adopted by the research-centric Indian pharmaceutical companies for selling innovative drug products across the globe, attaining global competitiveness, and maintaining a seamless supply chain through export initiatives have also been discussed in this book. Finally, the book figures out the relationship between R&D and financial performance with the help of panel data analysis (PDA), an econometric approach.
Corporate Crime in the Pharmaceutical Industry (Routledge Revivals)
Author: John Braithwaite
Publisher: Routledge
ISBN: 1135072906
Category : Social Science
Languages : en
Pages : 451
Book Description
First published in 1984, this book examines corporate crime in the pharmaceutical industry. Based on extensive research, including interviews with 131 senior executives of pharmaceutical companies in the United States, the United Kingdom, Australia, Mexico and Guatemala, the book is a major study of white-collar crime. Written in the 1980s, it covers topics such as international bribery and corruption, fraud in the testing of drugs and criminal negligence in the unsafe manufacturing of drugs. The author considers the implications of his findings for a range of strategies to control corporate crime, nationally and internationally.
Publisher: Routledge
ISBN: 1135072906
Category : Social Science
Languages : en
Pages : 451
Book Description
First published in 1984, this book examines corporate crime in the pharmaceutical industry. Based on extensive research, including interviews with 131 senior executives of pharmaceutical companies in the United States, the United Kingdom, Australia, Mexico and Guatemala, the book is a major study of white-collar crime. Written in the 1980s, it covers topics such as international bribery and corruption, fraud in the testing of drugs and criminal negligence in the unsafe manufacturing of drugs. The author considers the implications of his findings for a range of strategies to control corporate crime, nationally and internationally.
Performance of Pharmaceutical Companies in India
Author: Mainak Mazumdar
Publisher: Springer Science & Business Media
ISBN: 3790828750
Category : Business & Economics
Languages : en
Pages : 215
Book Description
This book explains how government support and institutional set up facilitated the evolution of the Indian pharmaceutical industry and provides an economic analysis of firm strategies due to recent policy changes. The book is useful for researchers interested in understanding the transition of a lifeline sector for an emerging economy like India. Students of public policy, health administrators and health economists who are interested in the functioning of the pharmaceutical sector that produces life saving drugs in developing nations will find this book useful. The book also provides good coverage on data envelopment analysis (DEA), a useful technique for understanding productivity and efficiency. It can provide guidance to the research students on the applicability of DEA technique to address various research questions for analysis. The book will be a valuable addition to libraries in colleges of pharmacy and medicine as well as to all other academic and research centers.
Publisher: Springer Science & Business Media
ISBN: 3790828750
Category : Business & Economics
Languages : en
Pages : 215
Book Description
This book explains how government support and institutional set up facilitated the evolution of the Indian pharmaceutical industry and provides an economic analysis of firm strategies due to recent policy changes. The book is useful for researchers interested in understanding the transition of a lifeline sector for an emerging economy like India. Students of public policy, health administrators and health economists who are interested in the functioning of the pharmaceutical sector that produces life saving drugs in developing nations will find this book useful. The book also provides good coverage on data envelopment analysis (DEA), a useful technique for understanding productivity and efficiency. It can provide guidance to the research students on the applicability of DEA technique to address various research questions for analysis. The book will be a valuable addition to libraries in colleges of pharmacy and medicine as well as to all other academic and research centers.